Brawn Biotech reports standalone net loss of Rs 0.61 crore in the December 2023 quarter
Sales decline 54.99% to Rs 2.84 crore
Net Loss of Brawn Biotech reported to Rs 0.61 crore in the quarter ended December 2023 as against net loss of Rs 0.04 crore during the previous quarter ended December 2022. Sales declined 54.99% to Rs 2.84 crore in the quarter ended December 2023 as against Rs 6.31 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales2.846.31 -55 OPM %-20.42-0.16 -PBDT-0.58-0.01 -5700 PBT-0.61-0.04 -1425 NP-0.61-0.04 -1425Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content